Acceleron Pharma reported $-63513000 in Pre-Tax Profit for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Abbvie ABBV:US $ 6290M 282M
Acceleron Pharma XLRN:US $ -63.51M 0.05M
Akebia Therapeutics AKBA:US $ -83.04M 13.46M
Alexion Pharmaceuticals ALXN:US $ 940.1M 164.6M
Arena Pharmaceuticals ARNA:US $ -146.1M 27.68M
Bayer BAYN:GR € 1537M 1825M
Bluebird Bio BLUE:US $ -231.42M 25.67M
Clovis Oncology CLVS:US $ -66.45M 0.04M
Dicerna Pharmaceuticals DRNA:US $ -40.27M 10.3M
Eli Lilly And LLY:US $ 1988.6M 80.6M
Exelixis EXEL:US $ 124.89M 126.9M
GlaxoSmithKline GSK:LN 1482M 225M
Johnson & Johnson JNJ:US $ 7776M 515M
Karyopharm Therapeutics KPTI:US $ -53448000 3.82M
Neurocrine Biosciences NBIX:US $ 57.5M 30.3M
Novartis NOVN:VX SF 4424M 620M
Ptc Therapeutics PTCT:US $ -117.88M 10.31M
Regeneron Pharmaceuticals REGN:US $ 3898.3M 2658.7M
Rigel Pharmaceuticals RIGL:US $ -14.79M 56.06M
Sangamo Biosciences SGMO:US $ -47.15M 1.47M
Tg Therapeutics TGTX:US $ -78.5M 12.13M
Ultragenyx Pharmaceutical RARE:US $ -121.96M 13.8M
United Therapeutics UTHR:US $ 216.5M 184M